The Canadian Biobank Alliance (CBA) emerged as an initiative of the Coronavirus Variants Rapid Response Network (CoVaRR-Net) during the peak of the COVID-19 pandemic to enhance Canada’s scientific research by establishing a national biobank network that supports material and data sharing for multi-jurisdictional studies.
The CBA connects 12 biobanks across Canada with each partner biobank maintaining custody over the materials and data they collect and store. To date, the CBA has collected over 500,000+ high-quality samples and longitudinal data from over 50,000 Canadians.
Whole blood, nasal swabs, breast milk, viruses, serum, saliva, stool, wastewater, cerebrospinal fluid, plasma, urine and environmental pathogens
